Page last updated: 2024-08-17

adenosine monophosphate and Cranial Nerve Diseases

adenosine monophosphate has been researched along with Cranial Nerve Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, DJ; Bhagani, S; Cropley, I; Filipe, A; Gifford, RJ; Gopal, R; Hopkins, S; Hughes, J; Jabeen, F; Jacobs, M; Johannessen, I; Karageorgopoulos, D; Lackenby, A; Lester, R; Liu, RS; MacConnachie, A; Mahungu, T; Marshall, N; Martin, D; Mepham, S; Orton, R; Palmarini, M; Patel, M; Perry, C; Peters, SE; Porter, D; Ritchie, D; Ritchie, ND; Rodger, A; Seaton, RA; Sreenu, VB; Templeton, K; Thomson, EC; Warren, S; Wilkie, GS; Zambon, M1

Other Studies

1 other study(ies) available for adenosine monophosphate and Cranial Nerve Diseases

ArticleYear
Late Ebola virus relapse causing meningoencephalitis: a case report.
    Lancet (London, England), 2016, Jul-30, Volume: 388, Issue:10043

    Topics: Acute Disease; Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Cranial Nerve Diseases; Disease Outbreaks; Drugs, Investigational; Ebolavirus; Female; Genome, Viral; Hemorrhagic Fever, Ebola; Humans; Meningoencephalitis; Nurses; Radiculopathy; Recurrence; Ribonucleotides; RNA, Viral; Scotland; Sierra Leone; Viral Load

2016